22 April 2016 Membrane-targeting liquid crystal nanoparticles (LCNPs) for drug delivery
Author Affiliations +
Abstract
In addition to maintaining the structural integrity of the cell, the plasma membrane regulates multiple important cellular processes, such as endocytosis and trafficking, apoptotic pathways and drug transport. The modulation or tracking of such cellular processes by means of controlled delivery of drugs or imaging agents via nanoscale delivery systems is very attractive. Nanoparticle-mediated delivery systems that mediate long-term residence (e.g., days) and controlled release of the cargoes in the plasma membrane while simultaneously not interfering with regular cellular physiology would be ideal for this purpose. Our laboratory has developed a plasma membrane-targeted liquid crystal nanoparticle (LCNP) formulation that can be loaded with dyes or drugs which can be slowly released from the particle over time. Here we highlight the utility of these nanopreparations for membrane delivery and imaging.
Conference Presentation
© (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Okhil K. Nag, Okhil K. Nag, Jawad Naciri, Jawad Naciri, Christopher M. Spillmann, Christopher M. Spillmann, James B. Delehanty, James B. Delehanty, "Membrane-targeting liquid crystal nanoparticles (LCNPs) for drug delivery", Proc. SPIE 9722, Colloidal Nanoparticles for Biomedical Applications XI, 972215 (22 April 2016); doi: 10.1117/12.2212529; https://doi.org/10.1117/12.2212529
PROCEEDINGS
6 PAGES + PRESENTATION

SHARE
Back to Top